Botulinum toxin therapy of writer's cramp
Authors:
- 1 February 2006
- journal article
- review article
- Published by Wiley in European Journal of Neurology
- Vol. 13 (s1) , 55-59
Abstract
The pathophysiology and management of writer's cramp is one of the most challenging amongst the various forms of focal dystonias. Frequently, the dystonic postures are confounded by compensatory muscle activity. Correct identification of target muscles for botulinum toxin (BT) injections determines the treatment success. The dosages of different preparations vary, with 1 unit of Botox® roughly equalling 3.5 units of Dysport®. Electromyographic guided injections yield better results and may also decrease the amount of toxin required. Weakness of target muscles interfering with other non‐writing activities is a frequently encountered adverse effect. Studies have shown that BT is a safe long‐term therapy option.Keywords
This publication has 43 references indexed in Scilit:
- A prevalence study of primary dystonia in eight European countriesJournal of Neurology, 2000
- Shortened cortical silent period in facial muscles of patients with cranial dystoniaNeurology, 2000
- Sex-related influences on the frequency and age of onset of primary dystoniaNeurology, 1999
- The pathophysiology of primary dystoniaBrain, 1998
- The Neurophysiology of DystoniaArchives of Neurology, 1998
- Abnormal cortical motor excitability in dystoniaNeurology, 1996
- Sex prevalence of focal dystonias.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Dystonia and tremor induced by peripheral trauma: predisposing factors.Journal of Neurology, Neurosurgery & Psychiatry, 1988
- Epidemiology of focal and generalized dystonia in Rochester, MinnesotaMovement Disorders, 1988
- WRITERS' CRAMP—A FOCAL DYSTONIABrain, 1982